Own stem cells may boost movement in kids with cerebral palsy

NCT ID NCT07527104

Recruiting now Disease control Sponsor: National Children's Hospital, Vietnam Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether injecting a child's own bone marrow cells into the spine, combined with rehabilitation, can improve motor function in children with cerebral palsy from birth injuries. Sixty children aged 1 to 6 years will be randomly assigned to receive either the cell treatment plus rehab or rehab alone. The main goal is to see if the cell group shows greater improvement in gross motor skills over 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: autologous bone marrow mononuclear cells (the child's own cells)
What this could lead to: If it works, this could offer a new way to improve motor function in children with cerebral palsy, potentially reducing lifelong disability.
What could go wrong: This is an early, small trial (60 children) with no placebo control. The procedure carries risks from bone marrow aspiration and spinal injection, and benefits may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy perinatal asphyxia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL PALSY HYPOXIC-ISCHEMIC ENCEPHALOPATHY INTRACRANIAL HEMORRHAGE

Contacts and locations

Locations

Vietnam National Children's Hospital
RECRUITING

Hanoi, Hanoi, 111111, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.